The ATP7B gene encodes a copper-transporting P-type ATPase (Cu-ATPase) primarily expressed in the liver, kidney, and brain. Unlike ATP7A (which absorbs copper from the intestine), ATP7B is crucial for hepatic copper excretion into bile and for delivering copper to ceruloplasmin. Mutations in ATP7B cause Wilson disease, an autosomal recessive disorder characterized by copper accumulation in the liver, brain, and cornea.
| Full Name | ATPase, Cu++ Transporting, Beta Polypeptide |
|---|
| Chromosomal Location | 13q14.3 |
|---|
| NCBI Gene ID | 540 |
|---|
| OMIM | 277900 |
|---|
| Ensembl ID | ENSG00000130291 |
|---|
| UniProt | P35602 |
|---|
| Protein Class | P-type ATPase (Cu-transporting) |
|---|
| Protein Size | 1651 amino acids (~165 kDa) |
|---|
| Associated Diseases | Wilson's Disease, Non-Wilsonian Hepatic Copper Accumulation, ATP7B-Related Neurodegeneration |
|---|
ATP7B shares structural homology with ATP7A but has distinct features:
- N-terminal metal-binding domain (MBD): Six copper-binding motifs (CXXC)
- Phosphatase domain (A domain): ATP hydrolysis
- Phosphorylation domain (P domain): Contains the DKTGTLT motif
- Transmembrane domain (T domain): Eight transmembrane helices
- ATP-binding domain (N domain): Nucleotide binding
- Unique C-terminal region: Contains a trafficking signal
- Biliary copper excretion: Primary route for copper elimination
- ATP7B localizes to the trans-Golgi network under normal conditions
- Upon copper loading: Redistributes to vesicles that fuse with canalicular membrane
- Copper incorporation into ceruloplasmin: Delivers copper for holo-ceruloplasmin synthesis
- Ceruloplasmin: Major copper-carrying protein in blood (95% of plasma copper)
- ATP7B delivers copper to apoceruloplasmin in the Golgi
- Holo-ceruloplasmin is secreted into circulation
- Ferroxidase activity: Ceruloplasmin oxidizes Fe2+ to Fe3+ for iron metabolism
- Primary expression: Liver (hepatocytes), kidney, placenta, brain
- Brain regions: Choroid plexus, basal ganglia, hippocampus
- Cellular localization: Hepatocyte canalicular membrane, trans-Golgi network
- Blood-brain barrier: Expressed in brain endothelial cells
- Inheritance: Autosomal recessive
- Incidence: 1 in 30,000-40,000
- Clinical features:
- Hepatic: Chronic hepatitis, cirrhosis, hepatic failure
- Neurological: Tremor, dysarthria, dystonia, parkinsonism
- Psychiatric: Depression, psychosis, behavioral changes
- Ocular: Kayser-Fleischer rings (copper deposits in cornea)
- Hematological: Hemolytic anemia
- Pathogenesis:
- Impaired biliary copper excretion → hepatic copper accumulation
- Copper release into bloodstream → extrahepatic deposition
- Oxidative stress and mitochondrial dysfunction
- Treatment:
- Chelators (penicillamine, trientine)
- Zinc salts (block copper absorption)
- Liver transplantation (for acute liver failure)
- Mechanism: Some ATP7B mutations impair ceruloplasmin synthesis
- Features: Iron accumulation, diabetes, neurodegeneration
- Brain regions affected: Basal ganglia (putamen, globus pallidus), thalamus, brainstem
- Mechanism: Copper-induced oxidative stress and mitochondrial dysfunction
- Dopaminergic neuron vulnerability: Similar to Parkinson's disease
ATP7B interacts with:
- COMMD1: Regulates ATP7B trafficking and stability
- Atox1: Copper chaperone delivering copper to ATP7B
- Hepatocystin (ATP7B partner): Involved in copper trafficking
- Ceruloplasmin (CP): Copper recipient for ceruloplasmin synthesis
- Chelation therapy: D-penicillamine, trientine (promote copper excretion)
- Zinc supplementation: Blocks intestinal copper absorption
- Dietary modifications: Low-copper diet
- Liver transplantation: For end-stage liver disease
- ATP7B knockout mice: Spontaneous copper accumulation model
- Transgenic models: Disease-specific mutations
-
Bull PC, et al. (1993). "The Wilson disease gene is a putative copper-transporting ATPase." Nat Genet. PMID:7683291 — Identification of ATP7B as Wilson disease gene.
-
Lutsenko S, et al. (2007). "Copper-transporting ATPases." Physiol Rev. PMID:17443135 — Comprehensive review.
-
Ferenci P. (2006). "Wilson's disease." Clin Liver Dis. PMID:17026714 — Clinical features and treatment.
-
Gitlin JD. (2003). "Wilson disease." Gastroenterology. PMID:12549587 — Pathogenesis review.
-
Bandmann O, et al. (2015). "Wilson's disease." Lancet. PMID:25487960 — Modern treatment approaches.
The study of Atp7B Gene Atpase Copper Transporting Beta has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.